These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 38365354)

  • 41. Anatomically Realistic Simulations of Liver Ablation by Irreversible Electroporation: Impact of Blood Vessels on Ablation Volumes and Undertreatment.
    Qasrawi R; Silve L; Burdío F; Abdeen Z; Ivorra A
    Technol Cancer Res Treat; 2017 Dec; 16(6):783-792. PubMed ID: 28093955
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evaluation of a robotic system for irreversible electroporation (IRE) of malignant liver tumors: initial results.
    Beyer LP; Pregler B; Michalik K; Niessen C; Dollinger M; Müller M; Schlitt HJ; Stroszczynski C; Wiggermann P
    Int J Comput Assist Radiol Surg; 2017 May; 12(5):803-809. PubMed ID: 27653615
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Irreversible electroporation. Current value for focal treatment of prostate cancer].
    Wendler JJ; Ganzer R; Hadaschik B; Blana A; Henkel T; Köhrmann KU; Machtens S; Roosen A; Salomon G; Sentker L; Witzsch U; Schlemmer HP; Baumunk D; Köllermann J; Schostak M; Liehr UB;
    Urologe A; 2015 Jun; 54(6):854-62. PubMed ID: 26024649
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cancer cells ablation with irreversible electroporation.
    Miller L; Leor J; Rubinsky B
    Technol Cancer Res Treat; 2005 Dec; 4(6):699-705. PubMed ID: 16292891
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Implications and considerations of thermal effects when applying irreversible electroporation tissue ablation therapy.
    Davalos RV; Bhonsle S; Neal RE
    Prostate; 2015 Jul; 75(10):1114-8. PubMed ID: 25809014
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of Focal vs Extended Irreversible Electroporation for the Ablation of Localized Low- or Intermediate-Risk Prostate Cancer on Early Oncological Control: A Randomized Clinical Trial.
    Zhang K; Teoh J; Laguna P; Dominguez-Escrig J; Barret E; Ramon-Borja JC; Muir G; Bohr J; de Reijke TM; Pelechano Gómez P; Ng CF; Sanchez-Salas R; de la Rosette J
    JAMA Surg; 2023 Apr; 158(4):343-349. PubMed ID: 36723911
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Histopathological Outcomes after Irreversible Electroporation for Prostate Cancer: Results of an Ablate and Resect Study.
    van den Bos W; Jurhill RR; de Bruin DM; Savci-Heijink CD; Postema AW; Wagstaff PG; Muller BG; Varkarakis IM; Skolarikos A; Zondervan PJ; Laguna Pes MP; de Reijke TM; de la Rosette JJ
    J Urol; 2016 Aug; 196(2):552-9. PubMed ID: 27004693
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Irreversible electroporation for the ablation of pancreatic malignancies: A patient-specific methodology.
    Latouche EL; Sano MB; Lorenzo MF; Davalos RV; Martin RCG
    J Surg Oncol; 2017 May; 115(6):711-717. PubMed ID: 28185295
    [TBL] [Abstract][Full Text] [Related]  

  • 49. First Delayed Resection Findings After Irreversible Electroporation (IRE) of Human Localised Renal Cell Carcinoma (RCC) in the IRENE Pilot Phase 2a Trial.
    Wendler JJ; Ricke J; Pech M; Fischbach F; Jürgens J; Siedentopf S; Roessner A; Porsch M; Baumunk D; Schostak M; Köllermann J; Liehr UB
    Cardiovasc Intervent Radiol; 2016 Feb; 39(2):239-50. PubMed ID: 26341653
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Irreversible electroporation (IRE): a narrative review of the development of IRE from the laboratory to a prostate cancer treatment.
    Blazevski A; Scheltema MJ; Amin A; Thompson JE; Lawrentschuk N; Stricker PD
    BJU Int; 2020 Mar; 125(3):369-378. PubMed ID: 31725935
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The correlation between the electrode configuration and histopathology of irreversible electroporation ablations in prostate cancer patients.
    van den Bos W; de Bruin DM; Jurhill RR; Savci-Heijink CD; Muller BG; Varkarakis IM; Skolarikos A; Zondervan PJ; Laguna-Pes MP; Wijkstra H; de Reijke TM; de la Rosette JJ
    World J Urol; 2016 May; 34(5):657-64. PubMed ID: 26296371
    [TBL] [Abstract][Full Text] [Related]  

  • 52. High-frequency irreversible electroporation (H-FIRE) for non-thermal ablation without muscle contraction.
    Arena CB; Sano MB; Rossmeisl JH; Caldwell JL; Garcia PA; Rylander MN; Davalos RV
    Biomed Eng Online; 2011 Nov; 10():102. PubMed ID: 22104372
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Irreversible Electroporation of the Pancreas Using Parallel Plate Electrodes in a Porcine Model: A Feasibility Study.
    Rombouts SJ; Nijkamp MW; van Dijck WP; Brosens LA; Konings M; van Hillegersberg R; Borel Rinkes IH; Hagendoorn J; Wittkampf FH; Molenaar IQ
    PLoS One; 2017; 12(1):e0169396. PubMed ID: 28052102
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Careful treatment planning enables safe ablation of liver tumors adjacent to major blood vessels by percutaneous irreversible electroporation (IRE).
    Kos B; Voigt P; Miklavcic D; Moche M
    Radiol Oncol; 2015 Sep; 49(3):234-41. PubMed ID: 26401128
    [TBL] [Abstract][Full Text] [Related]  

  • 55. In vivo irreversible electroporation kidney ablation: experimentally correlated numerical models.
    Neal RE; Garcia PA; Kavnoudias H; Rosenfeldt F; Mclean CA; Earl V; Bergman J; Davalos RV; Thomson KR
    IEEE Trans Biomed Eng; 2015 Feb; 62(2):561-9. PubMed ID: 25265626
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Development of a thermal model for irreversible electroporation: an approach to estimate and optimize the IRE protocols.
    Wardhana G; Almeida JP; Abayazid M; Fütterer JJ
    Int J Comput Assist Radiol Surg; 2021 Aug; 16(8):1325-1334. PubMed ID: 34032965
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Colorectal liver metastatic disease: efficacy of irreversible electroporation--a single-arm phase II clinical trial (COLDFIRE-2 trial).
    Scheffer HJ; Vroomen LG; Nielsen K; van Tilborg AA; Comans EF; van Kuijk C; van der Meijs BB; van den Bergh J; van den Tol PM; Meijerink MR
    BMC Cancer; 2015 Oct; 15():772. PubMed ID: 26497813
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Introduction to Irreversible Electroporation--Principles and Techniques.
    Thomson KR; Kavnoudias H; Neal RE
    Tech Vasc Interv Radiol; 2015 Sep; 18(3):128-34. PubMed ID: 26365541
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Synergistic combinations of short high-voltage pulses and long low-voltage pulses enhance irreversible electroporation efficacy.
    Yao C; Lv Y; Zhao Y; Dong S; Liu H; Ma J
    Sci Rep; 2017 Nov; 7(1):15123. PubMed ID: 29123231
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The role of the irreversible electroporation in the hepato-pancreatico-biliary surgery.
    Sánchez-Velázquez P; Clavien PA
    Cir Esp; 2017; 95(6):307-312. PubMed ID: 28318494
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.